REXULTI is just not approved to the treatment of men and women with dementia-similar psychosis without agitation that may well take place with dementia due to Alzheimer’s disease. The not long ago updated Cochrane review bundled 3 RCTs. Two small cross-above trials investigated IV ketamine in two doses31 or intrathecal https://vernonz111shw9.lotrlegendswiki.com/user